Displaying archives for Steven Young:

ALCMI Launches Genomics of Young Lung Cancer Study

Posted by Steven Young on February 5th, 2015 |

The Addario Lung Cancer Medical Institute (ALCMI) today launched a new study, the Genomics of Young Lung Cancer, to understand why lung cancer occurs in young adults, who quite often are athletic, never smokers and do not exhibit any of the known lung cancer genetic mutations.

Exosome Diagnostics & ALCMI Announce Collaboration on Sequencing Blood

Posted by Steven Young on December 8th, 2014 |

CAMBRIDGE, Mass. and LOS ANGELES, Calif., Jan. 9, 2015 – Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, today announced a strategic collaboration with the Addario Lung Cancer Medical Institute (ALCMI) to accelerate the development of its lead plasma-based diagnostics in development for mutation detection and monitoring in patients with lung cancer. The […]